✦ LIBER ✦

New cyclodextrin bioconjugates for active tumour targeting

✍ Scribed by Salmaso, Stefano; Bersani, Sara; Semenzato, Alessandra; Caliceti, Paolo

Book ID: 111984714
Publisher: Informa plc
Year: 2007
Tongue: English
Weight: 270 KB
Volume: 15
Category: Article
ISSN: 1061-186X
DOI: 10.1080/10611860701349752

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nanoparticle-Aptamer Bioconjugates: A Ne

Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells

✍ Farokhzad, O. C. 📂 Article 📅 2004 🏛 American Association for Cancer Research 🌐 English ⚖ 460 KB

Synthesis and Physicochemical Characteri

Synthesis and Physicochemical Characterization of Folate−Cyclodextrin Bioconjugate for Active Drug Delivery

✍ Caliceti, Paolo; Salmaso, Stefano; Semenzato, Alessandra; Carofiglio, Tommaso; F 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 700 KB

Cancer: New target for tumour immunother

Cancer: New target for tumour immunotherapy

✍ Flemming, Alexandra 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Functionalized diphenylchlorins and bact

Functionalized diphenylchlorins and bacteriochlorins: their synthesis and bioconjugation for targeted photodynamic therapy and tumour cell imaging

✍ Jonathan M. Sutton; Nelson Fernandez; Ross W. Boyle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

New strategies for targeting the hypoxic

New strategies for targeting the hypoxic tumour microenvironment in breast cancer

✍ Carol Ward; Simon P. Langdon; Peter Mullen; Adrian L. Harris; David J. Harrison; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 450 KB

VEGF-mediated tumour angiogenesis: a new

VEGF-mediated tumour angiogenesis: a new target for cancer therapy

✍ Georg Martiny-Baron; Dieter Marmé 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Considerable evidence is gathering for the involvement of vascular endothelial growth factor (VEGF) in the vascularization and growth of primary tumours as well as in the formation of metastases. The expression of VEGF depends on activated oncogenes and inactivated tumour suppressor genes as well as